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We previously observed that warts induced by an isolate of cottontail rabbit papillomavirus (CRPV) showed incomplete
instead of systemic regression in some domestic rabbits. We report that the viral isolate contained, as a major component,
a CRPV strain (CRPVb) showing an unexpectedly high divergence in the E6 and E7 open reading frames (ORFs), compared
to the prototype CRPVa present in the isolate as a minor component. The E6 and E7 oncoproteins of CRPVa and -b disclosed
only 87.5% identical amino acids and differed in size by three and two amino acids, respectively. This divergence involved
(i) a great number (4.4%) of nucleotide substitutions and a high rate (83.3%) of nonsynonymous mutations; (ii) mutations
changing the E6 and E7 stop codons; and (iii) in-frame sequence insertions in the E6 ORF (18 nucleotides) and downstream
of the mutated E7 stop codon (6 nucleotides), both likely to result from a duplication of adjacent sequences. These extensive
differences could account for distinct biological and antigenic properties. Strikingly, only four (0.8%) amino acids of the L1
major capsid protein were variable. Thus, it seems likely that sequence duplications and mutations affecting stop codons
exert a strong selection pressure on the fixation of nonsynonymous mutations and that phylogenetic calculations based
only on point mutations may misevaluate the time scale of the evolution of papillomaviruses. q 1997 Academic Press
The cottontail rabbit papillomavirus (CRPV) induces We previously found that systemic regression of rabbit
viral papillomas and malignant conversion of persistentskin warts in cottontail rabbits under natural conditions
and in domestic rabbits under experimental conditions warts were linked to class II genes of the major histocom-
patibility complex (MHC) (Han et al., 1992). We recently(Shope, 1933). Systemic regression of warts occurs in a
variable proportion of animals (Shope, 1933; Syverton, observed that rabbits homozygous for a specific MHC
class II DR-DQ haplotype displayed an unusual mode of1952; Kreider and Bartlett, 1981). Persistent warts may
evolve into invasive carcinoma (Rous and Beard, 1935; wart evolution characterized by the persistence of a few
warts only (Breitburd et al., 1997; J. Salmon, N. Chantel-Syverton, 1952). The major CRPV transcripts detected
in warts and carcinomas encode the E6 and E7 viral oup, F. Viard, O. Croissant, G. Orth, and F. Breitburd,
unpublished results). This prompted us to determineoncoproteins (Georges et al., 1984; Nasseri and
Wettstein, 1984; Danos et al., 1985; Wettstein, 1990). The whether a genetic heterogeneity of the CRPV isolate
could account for this phenomenon. In this paper, weE6 open reading frame (ORF) of CRPV is unique among
PVs by its greater size and its capacity to encode two show that the isolate contained two CRPV strains, the
prototype CRPV and, as a major component, a CRPVE6 proteins, which are translated in the same reading
frame from transcripts initiated at two different promoters subtype unrecognized so far and characterized by an
unexpectedly high extent of variation in the E6 and E7(Danos et al., 1985; Barbosa and Wettstein, 1988a;
Wettstein, 1990). Neither the long E6 protein (LE6) nor oncoproteins.
the short E6 protein (SE6) interacts with the p53 protein
(Harry and Wettstein, 1996), unlike the E6 protein of the MATERIALS AND METHODS
oncogenic genital human PVs (HPVs) (Howley, 1996). The
CRPV isolateCRPV E7 protein (Barbosa and Wettstein, 1988b) binds
the retinoblastoma protein (Haskell et al., 1993), like the CRPV particles were obtained from pooled cottontail
E7 protein of oncogenic genital HPVs. The CRPV E6 and rabbit warts provided in 1983 by Vearl Johnson (Rago,
E7 oncoproteins are likely to be among the targets of Kansas) and preserved in a 50% (v/v) glycerol-0.15 M
the cell-mediated immune responses involved in wart NaCl solution at/47 until use. Warts (10 g) were washed,
regression (Breitburd et al., 1997). minced, and ground in the presence of quartz powder in
10 vol of 100 mM phosphate buffer, pH 7.2, 50 mM NaCl,
10 mM EDTA. After two cycles of successive low-speed1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 33 1 45 68 89 66. and high-speed centrifugations (Favre et al., 1975), viral
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particles were resuspended in 1 ml of 50 mM phosphate Sequencing kit (Applied Biosystems) under the condi-
tions described by the manufacturer. Labeled DNA frag-buffer, pH 7.2, 100 mM NaCl, 1 mM EDTA. A 1/100 dilution
of this viral suspension induced confluent warts when ments were separated in a 4% acrylamide gel under de-
naturing conditions and analyzed using an ABI Prism 377applied onto scarified skin areas of New Zealand white
rabbits. automated sequence analyzer (Applied Biosystems). The
nucleotide sequence data reported in this paper have
been submitted to the GenBank nucleotide sequencePCR amplification and sequencing experiments
database and have been assigned Accession Nos.
U91410 for CRPVb E6-E7 sequences and U91411 forThe E6, E7, and L1 ORFs of the CRPV present in the
suspension, of the CRPVa and -b genomes cloned in CRPVb L1 sequence.
this study, and of the reference CRPV clone (a gift from
I. Giri, O. Danos, and M. Yaniv) were amplified by the Cloning of CRPVa and -b genomes
polymerase chain reaction (PCR) technique (Saiki et al.,
CRPV DNA was obtained by incubation of an aliquot1988), using primers deduced from the published CRPV
of the viral suspension in the presence of proteinase Knucleotide sequence (Giri et al., 1985). For PCR experi-
as described above, followed by a phenol–chloroformments performed on the viral suspension, a 1-ml aliquot
extraction. A CRPV DNA phage library was constructed(about 1011 particles) was diluted in 99 ml of 10 mM Tris –
by inserting the full-length viral DNA at the SacI site intoHCl, pH 7.5, 1 mM EDTA containing 100 mg of proteinase
the Lambda Zap II vector (Stratagene) (Short et al., 1988;K (Merck), incubated for 2 hr at 377, and then heated for
Sambrook et al., 1989), since SacI restriction endonucle-10 min at 907 to inactivate the enzyme. The E6 ORF was
ase, a one-cut enzyme for the reference CRPV DNA (Giriamplified as two overlapping fragments of 479 and 566
et al., 1985), was found to cleave the CRPVb DNA onlybasepairs and the E7 ORF as a single 513-basepair frag-
once (data not shown). After transfer hybridization ofment. Nucleotide positions of primers were nt 108– 128
phage plaques, cores were taken from a hundred posi-(5*-CGCATTGCCAGGAATTTCTGC-3*) and nt 586 – 563
tive plaques and analyzed by PCR amplification, using(5*-GGTCTGACAGTTTGCAAGAACTGC-3*), nt 441– 464
primers deduced from conserved E6 sequences flanking(5*-GTTCATGCGTTGTACAGTTTGCGG-3*) and nt 1006 –
the 18-nucleotide insertion specific for CRPVb and984 (5*-CAGCCCTGCGCACAGGATAGCAG-3*), and nt
localized at nucleotide positions 563–586 (5*-GCAGTT-918 –941 (5*-GCAGTCAGATCCAGTCTGTTTCTG-3*) and
CTTGCAAACTGTCAGACC-3*) and 694–674 (5*-GTT-nt 1430– 1409 (5*-GTCTAAACAGTCCGCTTCCGTG-3*).
CCTCCAGATCCACCGGAG-3*). Amplified sequences (aThe L1 ORF was amplified as three overlapping frag-
132-basepair fragment for CRPVa and a 150-basepairments of 620, 675, and 614 basepairs. Nucleotide
fragment for CRPVb) were analyzed by electrophoresis inpositions of primers were nt 5749– 5768 (5*-GAGGGT-
a 5% NuSieve low melting (FMC BioProducts, Rockland)AACGCAGATGGCAC-3*) and nt 6368 –6347 (5*-GTG-
agarose gel. Recombinant phage plaques were purifiedGTGGATCCTCTGCACACTG-3*), nt 6317– 6338 (5*-GCC-
and the recombinant pBluescript plasmids containingACAGGAGAACACTGGGCTC-3*) and nt 6991– 6970 (5*-
CRPVa or CRPVb genomes were excised from theCTTGACCTTACATAGCTGGAGC-3*), and nt 6940– 6961
Lambda Zap II vector following the instructions of the(5*-GCATGTGGAGGAGTATGAACTG-3*) and nt 7553 –
manufacturer (Stratagene).7533 (5*-CGATCAGGCTCAGTGCCAGCC-3*).
Universal forward and reverse M13 sequences were
RESULTSadded to the 5* ends of the forward and reverse primers,
respectively, to allow direct sequencing of the PCR prod- A CRPV strain with highly divergent E6 and E7
ucts. PCR experiments were performed with the Expand oncoproteins
High Fidelity PCR System (Boehringer Mannheim) follow-
ing the manufacturer’s instructions and using an auto- Our approach to characterizing the CRPV isolate has
been to determine the nucleotide sequence of the E6 andmated thermal cycler (GeneAmp 2400, Perkin–Elmer).
After a denaturation step of 2 min at 947, 10 cycles includ- E7 ORFs encoding the viral oncoproteins. The genetic
organization of the prototype CRPV E6 and E7 regioning a denaturation step of 15 sec at 947, an hybridization
step of the primers of 30 sec at 557, and an elongation (Giri et al., 1985) is depicted in Fig. 1A. DNA fragments
containing the translated region of the E6 ORF (startingstep of 45 sec at 727 were followed by 20 additional
cycles including incremented elongation steps (20 sec 25 nucleotides upstream of the initiation codon of the
LE6 protein) and the whole E7 ORF were amplified fromat each cycle). Amplification products were purified on
Centricon-100 columns (Amicon) and sequenced on both the DNA extracted from viral particles by using PCR.
Amplification products were sequenced on both strandsstrands by the dideoxynucleotide termination method
(Sanger et al., 1977), using fluorescent forward and re- by the dideoxynucleotide termination method (Sanger et
al., 1977). All conditions are described under Materialsverse M13 primers and the ABI Prism Dye-Primer Cycle
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FIG. 1. Sequence variations in the E6 and E7 ORFs of CRPVa and CRPVb. (A) Map of point mutations. The genetic organization of the E6 and
E7 region of the CRPVa genome (Giri et al., 1985) is represented at the top. Numbers indicate the positions of the first and last nucleotides of the
E6, E7, and E8 ORFs and the first nucleotide of the E1 ORF. The vertical dotted lines indicate the positions of the LE6, SE6, E7, and E8 initiation
codons. The distribution of nucleotide substitutions (vertical bars) within the E6, E7, and E8 ORFs and the beginning of the E1 ORF is indicated on
the two lines below the map. Synonymous (s) and non-synonymous (ns) mutations are represented. The E7 mutation common to the CRPVa and
CRPVb strains characterized in this study (c) and the positions of the 18- and 6-nucleotide insertions (arrowheads) are indicated above the upper
line. The mutations generating (w) or suppressing ((w)) a stop codon and the sequences encoding putative zinc fingers (Zf) (Danos et al., 1987)
are shown below the line. (B) Nucleotide and amino acid substitutions. Nucleotide positions are written vertically at the top. The numbering refers
to the CRPVa published sequence (Giri et al., 1985). Arrows indicate the beginning of the ORFs (solid line) and that of the translated part (dotted
line). Nucleotide substitutions in CRPVb as well as nucleotide insertions and their localizations are given beneath the corresponding CRPVa
nucleotides. Conserved nucleotides in the regions affected by stop codon variations are indicated by a dash and stop codons are shaded. Varied
nucleotide positions within the same codon are underlined. Amino acid changes and insertions are given beneath the corresponding nucleotides,
and stop codons (w) are indicated. Nucleotide sequences and deduced amino acid sequences (italics) adjacent to insertions, and likely to be
involved in a duplication event, are aligned beneath the 18- and 6-nucleotide insertions. Amino acids encoded by the 6 nucleotides downstream
of the CRPVa E7 stop codon are indicated in parentheses. The amino acid changes within the CRPVb E8 ORF are given beneath the corresponding
CRPVa nucleotides.
and Methods. When compared to the reference CRPV tations were nonsynonymous. One mutation generated a
stop codon, resulting in the deletion of the three carboxy-sequence (Giri et al., 1985), the nucleotide sequence of
the E6 and E7 ORFs of the isolate was characterized by terminal amino acids (Fig. 1B). On the whole, nucleotide
substitutions changed 31 (11.2%) amino acids of thea high rate of nonsynonymous point mutations and an
insertion of 18 and 6 nucleotides in the E6 and E7 ORFs, CRPVa LE6 protein, 23 of them (13.1%) being among the
176 carboxy-terminal amino acids that correspond to therespectively. Thus, the prototype CRPV will be referred
to hereafter as CRPVa and the novel strain as CRPVb. SE6 protein (Fig. 1A). Most of the amino acid changes
were nonconservative (Risler et al., 1988), and 17 affectedThirty-seven (4.4%) nucleotide positions were found
variable in the translated part (819 nucleotides) of the a charged amino acid residue, resulting in the overall
loss of a negatively charged residue for CRPVb LE6 andprototype E6 ORF. Mutations were distributed along the
whole E6 gene length (Fig. 1A). Twenty-nine (78.4%) mu- SE6 and the gain of a positively charged residue for
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CRPVb LE6. A sequence of 18 nucleotides was found
inserted between nucleotides 621 and 622, leading to a
6-amino-acid insertion shared by the LE6 and SE6 pro-
teins (Fig. 1B). This insertion resulted from the duplication
of the sequence immediately upstream (nucleotides 604
to 621), except for the four first nucleotides, which corre-
FIG. 2. Screening of CRPV recombinant phage for the presence of
sponded to the opposite strand (ATAG instead of TATC), an 18-nucleotide insertion in the E6 ORF. Cores were taken from 17
leading to two amino acid changes (Fig. 1B). CRPV recombinant phage plaques and amplified by PCR using oligonu-
cleotide primers flanking the 18-nucleotide insertion found in theOnly 8 (5.8%) variable residues were found among the
CRPVb E6 ORF. Amplified fragments were analyzed by electrophoresis140 amino-terminal amino acids of the LE6 protein, a
in a 5% NuSieve agarose gel. The DNA of the prototype CRPVa lackingregion that can be aligned with the E6 proteins of other
the insert (a) and an aliquot of the isolate containing CRPVb as a major
PVs (Danos and Yaniv, 1987). Only the first of the two component (b) taken as controls yielded 132-bp (CRPVa) and 150-bp
putative zinc-binding loops (with two cys-x-x-cys motifs (CRPVb) fragments after PCR amplification, using a 100-bp DNA ladder
(Gibco BRL) as a size marker (c). Of the 17 recombinant phage plaquesat their base) contained in this region (Fig. 1A) showed
analyzed (d to t), only one contained CRPVa (k).variable amino acids (Q40 r E; D62 r N). The 50 amino-
terminal amino acids of the SE6 protein (residues 98 to
147 of the LE6 protein) were conserved (Fig. 1A). Twenty- amino acids (between residues 11 and 27) (Barbosa and
three amino acid changes (17.8%) affected the 129 car- Wettstein, 1988a; Harry and Wettstein, 1996). Seven
boxy-terminal amino acids of the LE6 protein. Seven were (4.7%) nucleotide positions downstream of the first ATG
localized in the third putative zinc finger present at the (nucleotide 323) were found variable. Three corre-
carboxy-terminal end shared by the LE6 and SE6 proteins sponded to nonsynonymous mutations and resulted in
(Danos and Yaniv, 1987) (Fig. 1A). The TATAA sequence conservative amino acid changes (Fig. 1B).
(nucleotides 879 to 883) which represents the promoter
for the transcription of the E7 ORF (Danos et al., 1985) The prototype CRPV as a minor component of the
and the binding site for the viral E2 protein (ACCX6GGT) isolate
located in the 3* end of the E6 ORF (nucleotides 824 to
The sequencing of the E6 and E7 ORFs amplified from835) were preserved.
the viral suspension would not have allowed the detec-Fourteen (3.7%) of the 378 nucleotides of the prototype
tion of small amounts of the prototype CRPV or a closelyE7 ORF sequence were found to be variable. Eleven nucle-
related variant. This prompted us to clone full-lengthotide substitutions (3.9%) affected the translated region
CRPV genomes from the viral suspension by constructing(282 nucleotides) and corresponded to nonsynonymous
a CRPV DNA phage library. We screened for recombinantmutations. This resulted in the variation of 10 (10.6%) of
phages that contained CRPV genomes with or withoutthe 94 amino acids of the CRPVa E7 protein, including 4
the E6 18-nucleotide insert by using oligonucleotidenonconservative changes (Fig. 1B). Moreover, two genetic
primers flanking the insertion. A 150-basepair fragmentevents increasing the size of the E7 ORF and also affecting
typical of CRPVb was detected in 90 plaques and a 132-the 5*-untranslated part of the overlapping E1 ORF were
basepair fragment expected for a CRPV lacking the insertobserved: a mutation killing the E7 stop codon and an
in 4 plaques (Fig. 2). A mixture of the two fragments wasinsertion of 6 nucleotides (TACTGA). This insertion is likely
detected in two plaques and four plaques were negative.to result from a duplication of the nucleotide sequence
The nucleotide sequences of the E6 and E7 ORFs estab-(AAATGC) located immediately downstream in the 5*-un-
lished for two CRPVb clones were found to be identicaltranslated part of CRPVa E1 ORF (nt 1360–1365). The
to that determined directly from the viral suspension (Fig.mutated stop codon and 3 mutations in the duplicated
1). The sequences obtained for two clones of the minorsequence resulted in the addition of two amino acids at
component were found to be identical to the publishedthe carboxy-terminal end of the E7 protein and in the
prototype CRPVa E6 and E7 sequences (Giri et al., 1985),generation of a new stop codon (Fig. 1B). None of the
except for a mutation (T1012 r A) in the untranslatedmutations affected the 27 amino-terminal amino acids (Fig.
part of the E7 ORF which was also found in CRPVb. This1B), a region that includes the sequence LHCDE (amino
difference between the two CRPVa strains was con-acids 22 to 26), involved in the binding of the retinoblas-
firmed upon resequencing the reference CRPV clone (Giritoma protein (Haskell et al., 1993). Four amino acid
et al., 1985).changes were located in the zinc finger of the C-terminal
end (Danos and Yaniv, 1987) (Fig. 1A).
Low genetic variability of the CRPV L1 major capsid
The CRPV genome contains an E8 ORF (nucleotides
protein
182 to 472) (Giri et al., 1985), colinear with the E6 ORF
(Fig. 1A). The E8 ORF encodes a putative 50-amino-acid The extensive divergence of the E6 and E7 ORFs of
CRPVa and -b prompted us to analyze the genetic variabilityprotein containing two sequences of eight hydrophobic
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FIG. 3. Sequence variations in the L1 ORF of CRPVa and CRPVb. (A) Map of point mutations. The genetic organization of the region of the L1 ORF
of the CRPVa genome (Giri et al., 1985) is represented at the top. Numbers indicate the positions of the first and last nucleotides, the first ATG
(dotted line) of the L1 ORF, and the last nucleotide of the L2 ORF. The distribution of the synonymous (s) and nonsynonymous (ns) mutations and
the localization of the frameshift (fs) described below are indicated on the line beneath the map. (B) Corrected CRPVa sequence. Resequencing the
prototype CRPVa clone (Giri et al., 1985) disclosed the insertion of one nucleotide between positions 6888 and 6889 and the absence of nucleotide
6922. This generates a frameshift affecting 12 codons of the amino acid sequence deduced from the published CRPVa sequence (Giri et al., 1985).
Corrected nucleotide and amino acid sequences are represented compared to the published sequence. (C) Nucleotide and amino acid substitutions.
The positions of the variable nucleotides and amino acids are written vertically. The numbering refers to the corrected nucleotide sequence of CRPVa
(Giri et al., 1985). Amino acid changes resulting from nonsynonymous substitutions are given beneath the corresponding nucleotides.
of the L1 ORF encoding the major capsid protein (Fig. 3A). the low (about 0.5%) intratypic variability recognized for
CRPV so far (Brandsma et al., 1991; Georges et al., 1992;This ORF, together with the E6 and E7 ORFs, serves as
reference for the nomenclature of papillomaviruses and Harry and Wettstein, 1996). The single nucleotide change
found in the E6, E7, and L1 ORFs of the CRPVa isolatetheir classification into types, subtypes, and variants (How-
ley, 1996). The L1 ORF of two clones of each strain was described in this paper, compared to the prototype (Giri
sequenced as three overlapping fragments. The L1 ORF of et al., 1985), further substantiates the genetic stability
the minor CRPV component differed from the published of the prototype CRPV. According to the rules for the
CRPVa sequence (Giri et al., 1985) only by the insertion of nomenclature of PVs based on the comparison of the
one nucleotide (T) between nucleotides 6888 and 6889 and nucleotide sequence of the E6, E7, and L1 ORFs, 2 to
the deletion of another nucleotide (T6922) (Fig. 3B). The 10% nonidentical nucleotides define subtypes (Deau et
resulting frameshift affected 12 amino acids (residues 354 al., 1993; Howley, 1996). The overall percentage (3.2%)
to 365) (Fig. 3B). This difference was no longer found upon of nonidentical nucleotides in these ORFs of CRPVa and
resequencing the L1 ORF of the reference isolate, sug- -b warrants consideration of these strains as subtypes.
gesting that it was due to an error in the published se- The great intratype variability reported here for two
quence (Giri et al., 1985). We shall refer hereafter to the CRPV strains originating from the same batch of Kansas
corrected sequence as the prototype CRPV. Only 12 (0.8%) cottontail rabbit warts has most unusual features com-
of the 1515 nucleotides of the translated part of the proto- pared to other papillomaviruses (Van Ranst et al., 1992;
type L1 ORF were found to be different in the CRPVb se- Bernard et al., 1994).
quence (Figs. 3A and 3C). The mutations were evenly dis- (i) The divergence of the E6 and E7 proteins of CRPVa
tributed and none affected the 3* end of the L2 ORF overlap- and -b involved a great number of mutations, a high
ping the L1 ORF (Fig. 3A). Only 4 (0.8%) of the 505 amino proportion (83.5%) of nonsynonymous changes, and mu-
acids of the L1 protein were found to be variable (Fig. 3C). tations that changed stop codons in both E6 and E7
ORFs. This resulted in a high rate (around 12%) of amino
DISCUSSION acid changes, most of them nonconservative. By compar-
ison, the most divergent variants of HPV16 displayed onlyThe identification of a CRPV strain with a great varia-
tion in the E6 and E7 ORFs was unexpected in view of 3.8 and 2% amino acid changes in the E6 and E7 proteins,
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respectively (Myers et al., 1996). Study of the intratype mutational differences (Bernard et al., 1994) may miseval-
uate the time scale of evolutionary changes.variability of oncogenic genital HPVs has led to the as-
sumption that the fixation of as little as one mutation Numerous sequence variants have been identified
within HPV genotypes (Myers et al., 1996) but intratypein 300 basepairs required over several thousand years
(Bernard et al., 1994). This could suggest that CRPVa variations of the biological and antigenic properties of
viral proteins remain poorly documented (Bernard et al.,and -b diverged at least several tens of thousands of
years ago. 1994; Cheng et al., 1995). CRPV strains recoverable from
domestic rabbit warts provided the first example of a(ii) The divergence of the oncoproteins of CRPVa and
-b resulted also from in-frame duplications of nucleotide biological variation of CRPV (Shope, 1935). The existence
of cancer-producing variants was questioned (Rous,sequences. This, together with the mutations of stop co-
dons, led to an increase in size of CRPVb E6 and E7 1936) but could not be substantiated (Rous, 1943; Smith
et al., 1952; Rogers et al., 1960). We have recently shownproteins by 3 and 2 amino acids, respectively. HPV5 vari-
ants with a 9-amino-acid insertion in the L1 protein are that the cloned CRPVb DNA is infectious for domestic
rabbits (S. Caze´, J. Salmon, O. Croissant, G. Orth, F.the only other known example of intratype variability in-
volving a duplication of coding sequences (Kawase et Breitburd, unpublished results), as already reported for
CRPVa DNA (Georges et al., 1992). This should provideal., 1996). All these variants were found to share a rear-
rangement within the duplicated region and specific non- an opportunity to find out whether distinct biological
properties and oncogenic potential correspond to thesynonymous mutations (Kawase et al., 1996) that were
probably required to preserve the structural and func- extensive variation of CRPVa and -b oncoproteins.
tional integrity of the L1 protein. Many of the mutations
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